Estimation of plasma glutathione levels in NIDDM patients with and without cardiovascular disease

Axita C Vani, Hemanthkumar R G

Abstract


Diabetes mellitus is a group of metabolic derangements characterised by hyperglycemia resulting from defective insulin secretion or action or both. Persistent hyperglycemia generates reactive oxygen species causing oxidative damage to cells and various biomolecules. In this study the levels of reduced glutathione antioxidant were estimated in NIDDM patients with cardiovascular disease (n=50) by HPLC method and compared to healthy controls (n=50). The results indicated that plasma glutathione levels are significantly decreased showing that antioxidant defence is lowered in diabetic patients with cardiovascular complications.

 

.


Keywords


NIDDM, cardiovascular diseases,GSH(reduced Glutathione),HPLC

Full Text:

PDF

References


McDermott MM. The International Pandemic of Chronic Cardiovascular Disease. J of American Medical Association, 2007,297:1253-1255

Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European cardiovascular disease statistics. London: British Heart Foundation, (2005)

Powers A C. Diabetes Mellitus.Harrisons, Principles of Medicine.16th ed. New York.McGraw Hill.2005

Brahm Kumar tiwari, Kanti Bhooshan Pandey, A B Abidi,Syad Ibrahim Rizvi. Markers of oxidative stress during diabetes mellitus. Journal Of Biomarkers, 2013:1-8

Rajagopal V S et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes mellitus and restored by dietary supplementation with cysteine and glycine. Diabetes Care, 2011,34(1):162-167

A Negre Salvayre, R Salvayre N Auge, R Pamplona, Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal. 2009,11(12):3071-3109

P. Newsholme, E. P. Haber, S. M. Hirabara, E. L. O. Rebelato, J. Procopio, D. Morgan, H. C. Oliveira-Emilio, A. R. Carpinelli and R. Curi, Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol, 2007,583( 1): 9-24

Ballatori N,krance SM,Notenboom S,SHI S,Tieu K, Glutathione dysregulation and the etiology and progression of human diseases. Biological Chemistry.2009,390(3):191-214

Brownlee M, Biochemistry and molecular cell biology of diabetic complications. Nature, 2001,414(6865):813-820.

Loske C et al, Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm. 1998,105(8-9):1005-1015

Ubbink JB, Vermaak WJH, Bissbort S, Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991565:441-446

Araki A, Sako Y, Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr.1987, 422,:43-52

Christine M. Pfeiffer, Dan L. Huff and Elaine W. Gunter, Rapid and Accurate HPLC Assay for Plasma Total Homocysteine and Cysteine in a Clinical Laboratory Setting. Clin Chem.1999;45(2): 290-292

Khim Kuo, Rachel Still, Sara Cale and Ian McDowell.Standardization (External and Internal) of HPLC Assay for Plasma Homocysteine. Clin Chem .1997,43(9): 1653-1655

J W Baynes, Role of oxidative stress in development of complications in diabetes. Diabetes.1991, 40( 4):405-412

B Ramesh, R Karuna,R S Sreenivasa et al, Effect of cammiphora mukul gum resin on hepatic marker enzymes, lipid peroxidation and antioxidant status in pancreas and heart of streptozotocin induced diabetec rats. Asian Pac Trop Med.2012, 2(11): 895-900

D Gradinaru, CBorsa,C Ionescu and D Margina, ”Advanced oxidative and glycoxidative protein damage markers in elderly with type 2 diabetes mellitus. J Proteomics.2013,92:313-322

A P Piwowar, M Knapik and M Warwas, AOPP and its relation with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract.2007, 77(2): 188-192

C J Tsai, C J Hseich,S C Tung, M C Kuoand F C Shen, Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract.2012,98(2): 257-263

Y Dincer, T Akcay,Z Alademir and H Ilkowa, Assessment of DNA base oxidation and glutathione levels in patients with type 2 diabetes. Mutat Res.2002,505(12): 75-81

M Singh and M Shin, Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol.2009, 47( 1): 7-15

B S Varashree and P G Bhat, Correlation of lipid peroxidation and glycated hemoglobin levels in diabetes mellitus. Online J Health Allied Sci.2011, 10( 2): 1-4

Bronislav Zachara, Jolanta Gromadzinska, Wojciech Wasowicz and Zbigniew Zbrog, Red blood cell and plasma glutathione peroxidase activities and selenium concentrations in patients with chronic kidney disease:A review. Acta Biochim Pol.2006, 53(4): 663-677

Unger J, Reducing oxidative stress in patients with type 2 diabetes mellitus: a primary care call to action. Insulin.2008,3(3): 176-184

Nishikawa T,Edelstein D,Brownlee M, The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl.2000,77, S26-S309

Kai Soo Tan et al,Glutathione deficiency in type 2 Diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest.2012,122(6) :1925-1936

Roger Winters,Jansz Zukowski,Nuran Ercal, Richard Mathews and Douglas R Spitz, Analysis of Glutathione,Glutathione Disulfide, Cysteine, homocysteine and other biological thiols by HPLC following derivatization by N-(1-Pyrenyl) maleimide. Anal Biochem.1995,227,14-21,1995.




DOI: http://dx.doi.org/10.7439/ijbr.v6i7.2208

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.




Copyright (c) 2015 International Journal of Biomedical Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.